Literature DB >> 12609983

A rational approach to Re-engineer cytochrome P450 2B1 regioselectivity based on the crystal structure of cytochrome P450 2C5.

Santosh Kumar1, Emily E Scott, Hong Liu, James R Halpert.   

Abstract

The regioselectivity for progesterone hydroxylation by cytochrome P450 2B1 was re-engineered based on the x-ray crystal structure of cytochrome P450 2C5. 2B1 is a high K(m) progesterone 16alpha-hydroxylase, whereas 2C5 is a low K(m) progesterone 21-hydroxylase. Initially, nine individual 2B1 active-site residues were changed to the corresponding 2C5 residues, and the mutants were purified from an Escherichia coli expression system and assayed for progesterone hydroxylation. At 150 microm progesterone, I114A, F297G, and V363L showed 5-15% of the 21-hydroxylase activity of 2C5, whereas F206V showed high activity for an unknown product and a 13-fold decrease in K(m). Therefore, a quadruple mutant, I114A/F206V/F297G/V363L (Q), was constructed that showed 60% of 2C5 progesterone 21-hydroxylase activity and 57% regioselectivity. Based on their 2C5-like testosterone hydroxylation profiles, S294D and I477F alone and in combination were added to the quadruple mutant. All three mutants showed enhanced regioselectivity (70%) for progesterone 21-hydroxylation, whereas only Q/I477F had a higher k(cat). Finally, the remaining three single mutants, V103I, V367L, and G478V, were added to Q/I477F and Q/S294D/I477F, yielding seven additional multiple mutants. Among these, Q/V103I/S294D/I477F showed the highest k(cat) (3-fold higher than that of 2C5) and 80% regioselectivity for progesterone 21-hydroxylation. Docking of progesterone into a three-dimensional model of this mutant indicated that 21-hydroxylation is favored. In conclusion, a systematic approach to convert P450 regioselectivity across subfamilies suggests that active-site residues are mainly responsible for regioselectivity differences between 2B1 and 2C5 and validates the reliability of 2B1 models based on the crystal structure of 2C5.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12609983     DOI: 10.1074/jbc.M212515200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Do mammalian cytochrome P450s show multiple ligand access pathways and ligand channelling?

Authors:  Karin Schleinkofer; Peter J Winn; Susanne K Lüdemann; Rebecca C Wade
Journal:  EMBO Rep       Date:  2005-06       Impact factor: 8.807

2.  Re-engineering cytochrome P450 2B11dH for enhanced metabolism of several substrates including the anti-cancer prodrugs cyclophosphamide and ifosfamide.

Authors:  Ling Sun; Chong S Chen; David J Waxman; Hong Liu; James R Halpert; Santosh Kumar
Journal:  Arch Biochem Biophys       Date:  2007-01-08       Impact factor: 4.013

3.  Modification of small molecules by using cytochrome P450 expressed in Escherichia coli.

Authors:  Tomohide Uno; Atsushi Nakao; Satoko Masuda; Yuuki Taniguchi; Kengo Kanamaru; Hiroshi Yamagata; Masahiko Nakamura; Hiromasa Imaishi; Kiyoharu Oono
Journal:  J Ind Microbiol Biotechnol       Date:  2006-08-05       Impact factor: 3.346

4.  Investigation by site-directed mutagenesis of the role of cytochrome P450 2B4 non-active-site residues in protein-ligand interactions based on crystal structures of the ligand-bound enzyme.

Authors:  P Ross Wilderman; Sean C Gay; Hyun-Hee Jang; Qinghai Zhang; C David Stout; James R Halpert
Journal:  FEBS J       Date:  2011-11-25       Impact factor: 5.542

5.  Investigation of the role of cytochrome P450 2B4 active site residues in substrate metabolism based on crystal structures of the ligand-bound enzyme.

Authors:  Cynthia E Hernandez; Santosh Kumar; Hong Liu; James R Halpert
Journal:  Arch Biochem Biophys       Date:  2006-09-25       Impact factor: 4.013

Review 6.  Engineering cytochrome P450 enzyme systems for biomedical and biotechnological applications.

Authors:  Zhong Li; Yuanyuan Jiang; F Peter Guengerich; Li Ma; Shengying Li; Wei Zhang
Journal:  J Biol Chem       Date:  2019-12-06       Impact factor: 5.157

7.  Identification and analysis of conserved sequence motifs in cytochrome P450 family 2. Functional and structural role of a motif 187RFDYKD192 in CYP2B enzymes.

Authors:  Numan Oezguen; Santosh Kumar; Aditya Hindupur; Werner Braun; B K Muralidhara; James R Halpert
Journal:  J Biol Chem       Date:  2008-05-21       Impact factor: 5.157

Review 8.  Engineering cytochrome P450 biocatalysts for biotechnology, medicine and bioremediation.

Authors:  Santosh Kumar
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-02       Impact factor: 4.481

9.  Kinetic and molecular analysis of 5-epiaristolochene 1,3-dihydroxylase, a cytochrome P450 enzyme catalyzing successive hydroxylations of sesquiterpenes.

Authors:  Shunji Takahashi; Yuxin Zhao; Paul E O'Maille; Bryan T Greenhagen; Joseph P Noel; Robert M Coates; Joe Chappell
Journal:  J Biol Chem       Date:  2004-11-02       Impact factor: 5.157

10.  Controlled oxidation of remote sp3 C-H bonds in artemisinin via P450 catalysts with fine-tuned regio- and stereoselectivity.

Authors:  Kaidong Zhang; Brian M Shafer; Matthew D Demars; Harry A Stern; Rudi Fasan
Journal:  J Am Chem Soc       Date:  2012-11-02       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.